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Background: Musculoskeletal involvement occurs in 25% of patients with non-Hodgkin’s lymphoma (NHL). Primary
lymphoma in the joint is rare. It can present as a bone lesion or as atypical soft tissue proliferation. NHL has an
increased incidence in patients with autoimmune rheumatic diseases.
Case presentation: We present a case in which non-Hodgkin’s lymphoma was found coincidentally in the
synovium during knee joint replacement surgery in a 69-year old woman with rheumatoid arthritis. Pigmented,
vitreous tissue was resected, which turned out to be a diffuse large B-cell lymphoma after histological examination.
The coincidental intraoperative finding of intra-articular non-Hodgkin’s lymphoma was reported twice before,
presenting as synovial proliferation in elbow and shoulder surgery. In a few other cases non-Hodgkin’s lymphoma
presented most often in the knee, as a bone lesion or, when soft tissue was involved, as arthritis.
Conclusion: Non-Hodgkin’s lymphoma should be considered in patients with autoimmune rheumatic diseases. In
case of persistent arthritis, non-respondent to anti-inflammatory drugs, a biopsy might be warranted. Moreover,
when arthroscopy or arthrotomy is planned, any atypical tissue should be sent for histological analysis. Early
diagnosis of NHL can contribute to improved outcome of its rapidly developing treatment options.
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Non-Hodgkin’s Lymphoma (NHL) is a malignancy of the
lymphatic system of uncontrolled proliferation of B- or T-
lymphocytes. The musculoskeletal system is affected in 5-
25% of the patients [1–4]. Musculoskeletal involvement of
NHL has been reported before as a primary bone lesion or
as intra-articular soft tissue proliferation with arthritis as
presenting symptom. We present a case in which atypical
soft tissue found during a routine knee arthroplasty led to
the diagnosis systemic NHL.Case presentation
A 69-year old woman was referred to our clinic with
chronic left knee pain. Her walking distance was limited
and she complained of joint stiffness.* Correspondence: a.tenham@maartenskliniek.nl
1Sint Maartenskliniek, Department of Orthopaedics, Hengstdal 3, PO Box
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reproduction in any medium, provided the orMedical History
After a sports trauma 40 years ago, the patient under-
went a lateral meniscectomy of the left knee. Two loose
tissue parts were removed; histological analysis showed
synovial tissue with chronic inflammation possibly indi-
cating rheumatoid arthritis (RA). The following decades
she had internal and rheumatological examinations for
multiple joint pain and general body weakness. Multiple
joint osteoarthritis and rheumatoid factor (RF)-negative
RA were diagnosed. In 1997 a total knee arthroplasty
was performed on the right side. In 2006 the patient
consulted a rheumatologist for chronic fatigue, pain in
the left knee, elbow and both wrists and feet. Further la-
boratory and radiographic investigation yielded no other
diagnosis than RF-negative RA.
Examination
A vital woman was seen with a normal hip function. There
was a correctable valgus deformity of the left leg with
slight effusion of the knee and tenderness on palpation oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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range of motion was normal. A conventional X-ray
showed severe lateral osteoarthritis of the knee with loss
of height of the lateral tibial plateau (Figure 1A,B).
Surgery
With informed consent of the patient we decided to
proceed to a total knee replacement. Intraoperatively,
pigmented vitreous synovial tissue was seen in the sub-
cutaneous tissue, which was resected and sent to the
pathology department for further analysis. A total knee
replacement could be performed without any complica-
tions. The patient recovered well and was discharged five
days postoperatively.
Histology
Immunohistological analysis of the resected soft tissue
showed a large cell lymphoid proliferation under the syn-
ovial tissue surface with expression of B-cell antigen CD-
20 (Figure 2A-C). This finding matches the localization
of a B-cell NHL, WHO 2008 classified as diffuse large
B-cell lymphoma– not otherwise specified (DLBCL-
NOS). WHO guidelines suggest an Epstein Bar Virus-
negative B-cell lymphoma that develops around chronic-
ally inflamed joints in a patient with RA, as in the present
case, to be classified in this category.
Follow-up
Anamnesis and physical examination by an oncologist did
not reveal any clues for malignancy. But a PET-CT scan
showed pathologic enlarged lymph nodes along the aorta
and the left iliac and inguinal vessels. Lungs and liver were
clean in the scan and a bone marrow biopsy did not show
signs of tumor activity. The B-cell lymphoma was stagedFigure 1 An X-ray of the left knee showed severe osteoarthritis with
and a calcified medial meniscus. A. anteroposterior axis. B. lateral axis.level 2-E, therapy was started with rituximab, cyclofosfa-
mide, vincristine, doxorubicin and prednisone (R-CHOP)
combination chemotherapy in six doses.
Bone manifestation of NHL
In 5-25% of the patients with NHL, the bone is involved,
sometimes resulting in joint pain [1–4]. When this is the
primary symptom, imaging techniques can raise suspi-
cion of a malignancy. Also, bone surfaces during surgery
can be suspect. A NHL was once reported in the cutting
surface of the femur in a total knee arthroplasty [5]. A
routine analysis of 852 retrieved femoral heads in hip
arthroplasty confirms the possibility of bone involve-
ment [6]. In 14 femoral heads a low-grade B-cell lymph-
oma was detected. Systemic disease was found in only
two of these patients.
Synovial manifestation of NHL
The diagnosis in this case report was based on synovial
tissue analysis. This coincidental finding was reported
twice before, though this was in elbow and shoulder sur-
gery [2,7]. In a literature overview till 2006, 13 cases of
intra-articular synovial manifestation of NHL were pre-
sented, of which 11 cases concerned the knee [2]. All
patients presented with inflammation of the knee joint,
sometimes clinically simulating RA [1,2]. In later litera-
ture two more patients were strikingly described disco-
vering NHL with arthroscopy [3,8]. Both patients were
planned for a partial meniscectomy. One patient (51
years old) had a history of gonarthritis deformans, with-
out signs of inflammation of the knee. [8] The other pa-
tient (31 years old) had a constant knee pain and
swelling [3]. Arthroscopically obtained atypical synovial
tissue appeared to be a B-cell lymphoma in both cases.evident lateral joint space narrowing, bone sclerosis, osteophytes
Figure 2 In the synovial biopsy (A) a atypical lymphoid cell
proliferation is present under the synovial surface
(hematoxylin-eosin (HE), 2.5x) that (B) consists of a diffuse
proliferation of large lymphoid cells (HE, 40x), showing (C)
membranous expression of B-cell antigen CD20, which can be
seen as brown deposit (40x). This formed the histological
diagnosis Non-Hodgkin Lymphoma.
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tive RA have an increased risk of developing lymphoma
[7,9–11]. A recent review showed that aggressive B-cell
lymphomas, particularly the diffuse large B-cell lymph-
oma in the present case, are stronger associated withautoimmune rheumatic diseases than more indolent
lymphomas. Although the presence of NHL was less
associated with RA than with Sjögren’s syndrome and
systemic lupus erythematosus [10], a 28-fold increased
risk of NHL in patients with RA was found when severe
damage in the knee existed in the year prior to lymph-
oma diagnosis [11]. Most lymphomas in this population
are diffuse large B-cell lymphomas, which form an ag-
gressive subtype of NHLs. Though with new treatment
methods survival has significantly increased over the last
decade [12].
The main pathophysiological mechanisms for NHL are
B-cell hyperactivity and chronic inflammation [10]. Never-
theless, anti-inflammatory drugs are no treatment option
for NHL [12]. Probably through its malignant character,
NHL will be persistent to anti-inflammatory drugs, also in
case of musculoskeletal involvement. In relation with RA,
the rheumatic disease itself appears to have a larger effect
on the development of lymphoma than its therapy [10].
As the presented patient had used immunosuppressive
drugs (salazopyrine and leflunomide) for only two years,
the contribution of drugs can be expected to be minimal.
Part of the patients with a lymphoma is infected with the
Epstein-Barr Virus (EBV) [9]. The presence of EBV in the
lymphoma can have therapeutic consequences. Though,
in the presented case no EBV-encoded RNA was found
with in-situ hybridisation.Conclusions
To conclude we can say NHL seldom has its primary
presentation in a joint. If it occurs, it presents most
often in the knee as arthritis. To our knowledge we are
the first to present a coincidental finding of soft tissue
NHL in knee arthroplasty, without malignant bone path-
ology or signs of arthritis. However it is possible that the
lymphoma was partly responsible for the diffuse joint
pain and general body weakness this patient had for sev-
eral years.
In patients with a rheumatic disease, we advice to con-
sider NHL in the diagnostic work-up if arthritis does not
respond to anti-inflammatory drugs. In these cases a bi-
opsy may be warranted, since the risk of developing a
lymphoma is significantly increased in this population.
Moreover, when arthroscopy or arthrotomy is planned,
any atypical tissue should be sent for histological ana-
lysis. Early diagnosis of NHL can contribute to improved
outcome of its rapidly developing treatment options.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Series Editor of this journal.
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